Alvotech (ALVO)
4.175
-0.14
(-3.36%)
USD |
NASDAQ |
Feb 20, 13:55
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.301B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -63.14% |
| Valuation | |
| PE Ratio | 18.13 |
| PE Ratio (Forward) | |
| PS Ratio | 2.299 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -7.254 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg. |
| URL | http://www.alvotech.com |
| Investor Relations URL | https://investors.alvotech.com/ |
| HQ State/Province | Luxembourg |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Mar. 18, 2026 |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg. |
| URL | http://www.alvotech.com |
| Investor Relations URL | https://investors.alvotech.com/ |
| HQ State/Province | Luxembourg |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Mar. 18, 2026 |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |